Search hospitals

>

New Jersey

>

Hackensack

John Theurer Cancer Center at Hackensack University Medical Center

Claim this profile

Hackensack, New Jersey 07601

Global Leader in Cancer

Global Leader in Lung Cancer

Conducts research for Solid Tumors

Conducts research for Leukemia

Conducts research for Multiple Myeloma

346 reported clinical trials

18 medical researchers

Photo of John Theurer Cancer Center at Hackensack University Medical Center in HackensackPhoto of John Theurer Cancer Center at Hackensack University Medical Center in Hackensack

Summary

John Theurer Cancer Center at Hackensack University Medical Center is a medical facility located in Hackensack, New Jersey. This center is recognized for care of Cancer, Lung Cancer, Solid Tumors, Leukemia, Multiple Myeloma and other specialties. John Theurer Cancer Center at Hackensack University Medical Center is involved with conducting 346 clinical trials across 253 conditions. There are 18 research doctors associated with this hospital, such as Martin E Gutierrez, Robert Alter, MD, Donna McNamara, MD, and Tatyana Feldman, MD.

Area of expertise

1

Cancer

Global Leader

John Theurer Cancer Center at Hackensack University Medical Center has run 60 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
CCNE1 positive
2

Lung Cancer

Global Leader

John Theurer Cancer Center at Hackensack University Medical Center has run 51 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
KRAS positive

Top PIs

Clinical Trials running at John Theurer Cancer Center at Hackensack University Medical Center

Lung Cancer

Cancer

Solid Tumors

Breast Cancer

Multiple Myeloma

Non-Small Cell Lung Cancer

Prostate Cancer

Colorectal Cancer

Myelodysplastic Syndrome

Ovarian Cancer

Image of trial facility.

Anti-CD38 + KRAS Vaccine + Anti-PD-1

for Pancreatic & Lung Cancer

The goal of this clinical trial is to test the safety and tolerability of anti-CD38 monoclonal antibody (mAb), daratumumab, in combination with KRAS vaccine (Targovax TG-01/Stimulon QS-21) when given with anti-PD-1 (programmed cell death protein 1) mAb (nivolumab) in patients with advanced non-small cell lung cancer (NSCLC) or pancreatic ductal adenocarcinoma (PDAC). The main questions it aims to answer are: * How well does daratumumab and nivolumab, when given with a vaccine, control or stop these types of cancer? * How well does participants bodies handle these study drugs? * Does this combination of study drugs help participants live longer? Participants will receive daratumumab, nivolumab with KRAS vaccine and have regular tests and procedures to follow how the participants are doing on these study drugs.

Recruiting

1 award

Phase 2

13 criteria

Image of trial facility.

V940 + Pembrolizumab

for Lung Cancer

This trial is testing a new treatment combination of V940 and pembrolizumab in patients who have had surgery to remove Stage II, IIIA, or IIIB non-small cell lung cancer. The goal is to see if this new combination can help prevent the cancer from coming back. V940 and pembrolizumab work together to help the immune system find and destroy any leftover cancer cells.

Recruiting

1 award

Phase 3

7 criteria

Image of trial facility.

PF-06821497

for Small Cell Lung Cancer

This trial is testing a new drug called PF-06821497 to see if it can help adults with certain hard-to-treat cancers. The drug is taken by mouth and is being studied alone or with other treatments to check its safety and effectiveness in stopping cancer growth.

Recruiting

1 award

Phase 1

5 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at John Theurer Cancer Center at Hackensack University Medical Center?

Where is John Theurer Cancer Center at Hackensack University Medical Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does John Theurer Cancer Center at Hackensack University Medical Center accept?

What awards or recognition has John Theurer Cancer Center at Hackensack University Medical Center received?